Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VNRX-7145 and ceftibuten drug-drug interaction study in healthy volunteers
NCT04877379Phase 1Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- Jun 2021
- Primary completion
- Nov 2021
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 1, randomised trial of ledaborbactam etzadroxil (6 arms), sponsored by Basilea Pharmaceutica. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from Time Zero to Infinity and 1 more. Started Jun 2021; status: completed.
02
Drugs
ledaborbactam etzadroxil
Beyond the preview
Go deeper on NCT04877379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04877379.